Some people say that a good partnership is best built between equals. However, as a small biotech you may not find a suitable CDMO partner with a similar size as your company. What are the options then for a small, agile business? You need a high-quality outcome but you want to keep your options open and avoid painting yourself into a corner. The good news is that you don't have to.
By leveraging the expertise of a large, experienced CDMO in the right way, using the right business model, you can maximize the attractiveness of your program whatever your future strategy might be. This includes using a platform process that will facilitate regulatory approval and advanced manufacturing techniques that maximizes your chances to succeed.
By doing this, you’ll accelerate your path to market while simultaneously positioning your candidate well for future milestones. This enables you to hit important inflection points on time, giving you the power to preserve all of your options—whether that is selling, partnering, or commercializing your drug with or without your CDMO.
Ibex™ solutions consist of three CDMO offerings: Ibex™ Design, Ibex™ Develop and Ibex™ Dedicate that span the complete biopharmaceutical lifecycle- from preclinical to commercial stages, from drug substance to drug product, all in one location. The variety of solutions offerings provide the flexibility of a complete program - from gene to drug product, or the option to drop in at a later stage depending where you are in your journey.